Clin Mol Hepatol.  2022 Apr;28(2):269-272. 10.3350/cmh.2022.0040.

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs

Affiliations
  • 1Department of Dermatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
  • 2Department of Dermatology, Kurume University School of Medicine, Kurume, Japan
  • 3Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
  • 4Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan

Keyword

Non-alcoholic fatty liver disease; Metabolic diseases; Psoriasis; Interleukin-17; Liver fibrosis
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr